Cell Adhesion Sheet Using Formula 1 Compound for Selective Cancer Cell Capture

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing cell adhesion sheets, particularly those formed from hydratable compositions for cancer cell sorting, face challenges in suppressing platelet adhesion while achieving excellent cell adhesion, especially for cancer cells.

Innovation Solution

A cell adhesion sheet formed from a composition containing a compound represented by Formula (1), where X is a nitrogen atom or >CR 102< -, and R 3< is an alkyl group with 4 or less carbon atoms, effectively suppresses platelet adhesion while enhancing cell adhesion, particularly for cancer cells.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Strength

If a hydratable composition is used for cancer cell sorting, then cell adhesion is improved, but platelet adhesion is not sufficiently suppressed

Engineering Contradiction:
Improvecell adhesionVSAvoidplatelet adhesion
Core Design Contradiction:
StrengthVSObject-affected harmful factors

Solution Approach 1:

The patent modifies the chemical structure of the adhesion-promoting group by introducing specific substituents (Formula 1) that change the interaction parameters with different cell types. This allows selective adhesion where cancer cells adhere strongly while platelets are suppressed, resolving the contradiction between general cell adhesion and platelet adhesion control.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent creates a surface with localized adhesion properties by using specific functional groups that exhibit different adhesion characteristics for different cell types. The adhesion-promoting group in Formula (1) provides localized selective binding sites that preferentially interact with cancer cells while repelling platelets, achieving spatially differentiated adhesion behavior.

Inventive Principle:
Principle #3Local quality

2Ease of manufacture

If conventional adhesion materials are used, then manufacturing is simple, but selective adhesion of cancer cells cannot be achieved

Engineering Contradiction:
Improvemanufacturing simplicityVSAvoidselective adhesion performance
Core Design Contradiction:
Ease of manufactureVSManufacturing precision

Solution Approach 1:

The patent modifies existing adhesion materials by incorporating specific functional groups (Formula 1) that change the adhesion selectivity parameter. This allows conventional manufacturing methods to be used while achieving enhanced selective adhesion of cancer cells, resolving the contradiction between manufacturing simplicity and adhesion precision.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The cell adhesion sheet achieves selective adhesion of cells, particularly cancer cells, while minimizing platelet adhesion, thereby facilitating efficient capture and detection of circulating cancer cells in blood.

Implementation Method 1

the adhesion of platelets is suppressed

Methodology Applied
Scientific EffectAnti-thrombogenic effect:

Implementation Method 2

the adhesion of cells is excellent

Methodology Applied
Scientific EffectAdhesion: Adhesive

Data Source

PatentEP3916079B1Sheet for cell attachment
Publication Date: 2025.05.14 FUJIFILM CORP
  • EP3916079B1 patent drawing
  • EP3916079B1 patent drawing
  • EP3916079B1 patent drawing

AI summary

The present invention provides a cell adhesion sheet in which the adhesion of platelets is suppressed and the adhesion of cells is excellent. The cell adhesion sheet according to the embodiment of the present invention is formed of a composition containing a compound represented by Formula (1).